Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.57%
#2 Palladium Network Palladium Network +6.43%
#3 Cryptopia Cryptopia +4.36%
#4 SIXSEVEN SIXSEVEN +4.11%
#5 Kinetiq Kinetiq +3.41%
#6 Test Test +3.32%
#7 Movement Movement +3.31%
#8 Victoria VR Victoria VR +3.17%
#9 Jito Jito +3.05%
#10 COTI COTI +3.02%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Arno Therapeutics, Inc. Arno Therapeutics, Inc.

Arno Therapeutics, Inc.

ARNI
Classement en actions #42094
Arno Therapeutics, Inc., headquartered in Flemington, New Jersey, operates as a... Arno Therapeutics, Inc., headquartered in Flemington, New Jersey, operates as a biopharmaceutical enterprise focused on discovering and advancing treatments for cancer and other severe health conditions. The company's developmental portfolio includes several key compounds: Onapristone, a type 1 anti-progestin hormone blocker, is currently undergoing Phase I/II clinical trials. This therapeutic is being investigated for its efficacy in treating various solid tumors, such as breast and endometrial cancers in post-menopausal women, and advanced castration-resistant prostate cancer in men. AR-12, an orally administered cancer therapy, has successfully completed Phase I clinical studies for solid tumors and hematological malignancies. Additionally, it is in pre-clinical development for potential applications against a range of microbial targets. AR-42, another innovative oral cancer treatment, is involved in a Phase I investigator-initiated clinical study, targeting both hematological malignancies and solid tumors. To support its research and development efforts, Arno Therapeutics has established licensing agreements with Invivis Pharmaceuticals, Inc., the Regents of the University of Minnesota, and the Ohio State University Innovation Foundation. The company also holds a co-development partnership with Leica Biosystems Newcastle Ltd.
Prix de l'action
$0.0001
Dernière synchronisation: 2026-08-11
Capitalisation boursière
$4.94K
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Arno Therapeutics, Inc. (ARNI)

Catégorie

Healthcare
Le prix ARNI avec la capitalisation boursière de B
Arno Therapeutics, Inc. Arno Therapeutics, Inc.
ARNI
$0.0001
Capitalisation boursière de Arno Therapeutics, Inc.(ARNI)
Capitalisation boursière: $4.94K
En August 2026, Arno Therapeutics, Inc. a une capitalisation boursière de $4.94K. Cela fait de Arno Therapeutics, Inc. la 42094th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Arno Therapeutics, Inc. du 2008 au 2026
ARNI par rapport au top 5 des plus populaires stocks
Prix pour ARNI L’actif B La capitalisation boursière de B Résultats
Arno Therapeutics, Inc. Arno Therapeutics, Inc.
$109,085 $4.94K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.383T +109,085,297,974.98%
Arno Therapeutics, Inc. Arno Therapeutics, Inc.
$89,633.05 $4.94K
Apple Inc. Apple Inc.
AAPL
$4.423T +89,633,053,673.82%
Arno Therapeutics, Inc. Arno Therapeutics, Inc.
$84,303.33 $4.94K
Alphabet Inc. Alphabet Inc.
GOOG
$4.160T +84,303,331,188.39%
Arno Therapeutics, Inc. Arno Therapeutics, Inc.
$74,231.43 $4.94K
Microsoft Corporation Microsoft Corporation
MSFT
$3.663T +74,231,425,168.49%
Arno Therapeutics, Inc. Arno Therapeutics, Inc.
$58,586.20 $4.94K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.891T +58,586,196,362.01%